These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 38066484)
21. Preoperative C-reactive protein to albumin ratio predicts anastomotic leakage after esophagectomy for thoracic esophageal cancer: a single-center retrospective cohort study. Sugimoto A; Toyokawa T; Miki Y; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Muguruma K; Yashiro M; Ohira M BMC Surg; 2021 Sep; 21(1):348. PubMed ID: 34548054 [TBL] [Abstract][Full Text] [Related]
22. Robot-assisted Versus Conventional Minimally Invasive Esophagectomy for Resectable Esophageal Squamous Cell Carcinoma: Early Results of a Multicenter Randomized Controlled Trial: the RAMIE Trial. Yang Y; Li B; Yi J; Hua R; Chen H; Tan L; Li H; He Y; Guo X; Sun Y; Yu B; Li Z Ann Surg; 2022 Apr; 275(4):646-653. PubMed ID: 34171870 [TBL] [Abstract][Full Text] [Related]
23. Early postoperative endoscopy for predicting anastomotic leakage after minimally invasive esophagectomy: A large-volume retrospective study. Ma S; Zhu J; Xue M; Shen Y; Xiong Y; Zheng K; Tang X; Wang L; Ni Y; Jiang T; Zhao J Surgery; 2024 May; 175(5):1305-1311. PubMed ID: 38342728 [TBL] [Abstract][Full Text] [Related]
24. Minimally invasive esophagectomy attenuates the postoperative inflammatory response and improves survival compared with open esophagectomy in patients with esophageal cancer: a propensity score matched analysis. Yamashita K; Watanabe M; Mine S; Toihata T; Fukudome I; Okamura A; Yuda M; Hayami M; Ishizuka N; Imamura Y Surg Endosc; 2018 Nov; 32(11):4443-4450. PubMed ID: 29644466 [TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant chemoradiotherapy, chemotherapy, and radiotherapy do not significantly increase the incidence of anastomotic leakage after esophageal cancer surgery: a meta-analysis. Jin Z; Zhang J; Chen D; Wu S; Xue P; Zhu K; Xu C; Zhu C; Zhang B Dis Esophagus; 2022 Sep; 35(9):. PubMed ID: 34952537 [TBL] [Abstract][Full Text] [Related]
26. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy. Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140 [TBL] [Abstract][Full Text] [Related]
27. Influence of Neoadjuvant Chemotherapy on Short-term Outcomes After Minimally Invasive Esophagectomy for Esophageal Cancer. Nomoto D; Yoshida N; Akiyama T; Kiyozumi Y; Eto K; Hiyoshi Y; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Miyamoto Y; Baba H Anticancer Res; 2019 Jan; 39(1):471-475. PubMed ID: 30591497 [TBL] [Abstract][Full Text] [Related]
28. Intrathoracic vs Cervical Anastomosis After Totally or Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer: A Randomized Clinical Trial. van Workum F; Verstegen MHP; Klarenbeek BR; Bouwense SAW; van Berge Henegouwen MI; Daams F; Gisbertz SS; Hannink G; Haveman JW; Heisterkamp J; Jansen W; Kouwenhoven EA; van Lanschot JJB; Nieuwenhuijzen GAP; van der Peet DL; Polat F; Ubels S; Wijnhoven BPL; Rovers MM; Rosman C; JAMA Surg; 2021 Jul; 156(7):601-610. PubMed ID: 33978698 [TBL] [Abstract][Full Text] [Related]
29. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma. Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154 [TBL] [Abstract][Full Text] [Related]
30. Reliability and safety of minimally invasive esophagectomy after neoadjuvant chemoradiation: a retrospective study. Liu G; Han Y; Peng L; Wang K; Fan Y J Cardiothorac Surg; 2019 May; 14(1):97. PubMed ID: 31138245 [TBL] [Abstract][Full Text] [Related]
31. Techniques and short-term outcomes for total minimally invasive Ivor Lewis esophageal resection in distal esophageal and gastroesophageal junction cancers: pooled data from six European centers. Straatman J; van der Wielen N; Nieuwenhuijzen GA; Rosman C; Roig J; Scheepers JJ; Cuesta MA; Luyer MD; van Berge Henegouwen MI; van Workum F; Gisbertz SS; van der Peet DL Surg Endosc; 2017 Jan; 31(1):119-126. PubMed ID: 27129563 [TBL] [Abstract][Full Text] [Related]
32. Impact of post-operative serum albumin level on anastomotic leakage after transthoracic oesophagectomy for oesophageal squamous cell carcinoma. Zhuge L; Zheng D; Mao H; Xiang J; Chen H ANZ J Surg; 2021 Jan; 91(1-2):E7-E13. PubMed ID: 33155410 [TBL] [Abstract][Full Text] [Related]
33. A standardized comparison of peri-operative complications after minimally invasive esophagectomy: Ivor Lewis versus McKeown. Brown AM; Pucci MJ; Berger AC; Tatarian T; Evans NR; Rosato EL; Palazzo F Surg Endosc; 2018 Jan; 32(1):204-211. PubMed ID: 28643075 [TBL] [Abstract][Full Text] [Related]
34. The impact of combined thoracoscopic and laparoscopic surgery on pulmonary complications after radical esophagectomy in patients with resectable esophageal cancer. Kubo N; Ohira M; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Shibutani M; Yamazoe S; Kimura K; Nagahara H; Amano R; Ohtani H; Yashiro M; Maeda K; Hirakawa K Anticancer Res; 2014 May; 34(5):2399-404. PubMed ID: 24778050 [TBL] [Abstract][Full Text] [Related]
35. Minimally Invasive Esophagectomy with Thoracic Duct Resection Post Neoadjuvant Chemoradiotherapy for Carcinoma Esophagus-Impact on Lymph Node Yield and Hemodynamic Parameters. Anand S; Kalayarasan R; Chandrasekar S; Gnanasekaran S; Pottakkat B J Gastrointest Cancer; 2019 Jun; 50(2):230-235. PubMed ID: 29344808 [TBL] [Abstract][Full Text] [Related]
36. Comparisons between minimally invasive and open esophagectomy for esophageal cancer with cervical anastomosis: a retrospective study. Li Z; Liu C; Liu Y; Yao S; Xu B; Dong G J Cardiothorac Surg; 2020 Jun; 15(1):128. PubMed ID: 32513211 [TBL] [Abstract][Full Text] [Related]
37. Investigation of operative outcomes of thoracoscopic esophagectomy after triplet chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for advanced esophageal squamous cell carcinoma. Akiyama Y; Iwaya T; Endo F; Chiba T; Takahara T; Otsuka K; Nitta H; Koeda K; Mizuno M; Kimura Y; Sasaki A Surg Endosc; 2018 Jan; 32(1):391-399. PubMed ID: 28664431 [TBL] [Abstract][Full Text] [Related]
38. Risk Factors for Postoperative Anastomosis Leak After Esophagectomy for Esophageal Cancer. Aoyama T; Atsumi Y; Hara K; Tamagawa H; Tamagawa A; Komori K; Hashimoto I; Maezawa Y; Kazama K; Kano K; Murakawa M; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y In Vivo; 2020; 34(2):857-862. PubMed ID: 32111795 [TBL] [Abstract][Full Text] [Related]
39. A successful clinical pathway protocol for minimally invasive esophagectomy. Merritt RE; Kneuertz PJ; D'Souza DM; Perry KA Surg Endosc; 2020 Apr; 34(4):1696-1703. PubMed ID: 31286257 [TBL] [Abstract][Full Text] [Related]
40. [Efficacy comparison of Sweet versus Ivor-Lewis esophagectomy in the treatment of middle-lower esophageal squamous cell carcinoma]. Yang X; Zhan C; Sun F; Chen L; Shi M; Jiang W; Wang Q Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):979-984. PubMed ID: 27680063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]